Cambrex Corp., a manufacturer of small molecule innovator and generic APIs, has expanded large scale manufacturing capacity at its cGMP facility in Karlskoga, Sweden and has introduced additional continuous flow manufacturing for the production of high purity intermediates.   The expansion includes the installation of new multi-purpose reactors ranging from 4m3 to 12m3 and upgrading of the control room within an existing plant on site. This extra capacity increases the large scale manufacturin...